{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:13:11Z","timestamp":1760141591035,"version":"build-2065373602"},"reference-count":51,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.ejso.2022.01.018","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T19:58:11Z","timestamp":1646423891000},"page":"1768-1777","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["A novel hematological classifier predicting chemotherapy benefit and recurrence hazard for locally advanced gastric cancer A multicenter IPTW analysis"],"prefix":"10.1016","volume":"48","author":[{"given":"Jun","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiao-bao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin-bin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua-Long","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo-sheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-li","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao-Hui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Xian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi-Yue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long-Long","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Wei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-sheng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0019-885X","authenticated-orcid":false,"given":"Chang-Ming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejso.2022.01.018_bib1","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/apt.12814","article-title":"Review article: the epidemiology and prevention of gastric cancer","volume":"40","author":"Fock","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.ejso.2022.01.018_bib2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/SLA.0000000000002040","article-title":"Lauren histologic type is the most important factor Associated with pattern of recurrence following resection of gastric adenocarcinoma","volume":"267","author":"Lee","year":"2018","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.ejso.2022.01.018_bib3","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1007\/s10120-019-00936-w","article-title":"The predictive value of the preoperative C-reactive protein-albumin ratio for early recurrence and chemotherapy benefit in patients with gastric cancer after radical gastrectomy: using randomized phase III trial data","volume":"22","author":"Xu","year":"2019","journal-title":"Gastric Cancer"},{"issue":"7","key":"10.1016\/j.ejso.2022.01.018_bib4","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/bjs.10502","article-title":"Locoregional relapse after gastrectomy with D2 lymphadenectomy for gastric cancer","volume":"104","author":"Chang","year":"2017","journal-title":"Br J Surg"},{"issue":"1","key":"10.1016\/j.ejso.2022.01.018_bib5","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1186\/s12885-018-4341-6","article-title":"Survival after recurrence in patients with gastric cancer who receive S-1 adjuvant chemotherapy: exploratory analysis of the ACTS-GC trial","volume":"18","author":"Ito","year":"2018","journal-title":"BMC Cancer"},{"issue":"18","key":"10.1016\/j.ejso.2022.01.018_bib6","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1056\/NEJMoa072252","article-title":"Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine","volume":"357","author":"Sakuramoto","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"17","key":"10.1016\/j.ejso.2022.01.018_bib7","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.2010.534","article-title":"Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis","volume":"303","author":"Paoletti","year":"2010","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.ejso.2022.01.018_bib8","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S1470-2045(14)70473-5","article-title":"Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial","volume":"15","author":"Noh","year":"2014","journal-title":"Lancet Oncol"},{"year":"2020","series-title":"Japanese gastric cancer treatment guidelines 2018","key":"10.1016\/j.ejso.2022.01.018_bib9"},{"issue":"2","key":"10.1016\/j.ejso.2022.01.018_bib11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/SLA.0000000000002803","article-title":"Microsatellite instability and programmed cell death-ligand 1 expression in stage II\/III gastric cancer: post hoc analysis of the CLASSIC randomized controlled study","volume":"270","author":"Choi","year":"2019","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.ejso.2022.01.018_bib12","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/SLA.0000000000002116","article-title":"ImmunoScore signature: a prognostic and predictive tool in gastric cancer","volume":"267","author":"Jiang","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2022.01.018_bib13","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/SLA.0000000000002058","article-title":"Tumor-infiltrating neutrophils is prognostic and predictive for postoperative adjuvant chemotherapy benefit in patients with gastric cancer.[J]","volume":"267","author":"Zhang","year":"2018","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ejso.2022.01.018_bib14","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1245\/s10434-015-4814-7","article-title":"Predictive potential of preoperative nutritional status in long-term outcome projections for patients with gastric cancer.[J]","volume":"23","author":"Sakurai","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2022.01.018_bib15","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/SLA.0b013e3181e9819a","article-title":"Preoperative hypoalbuminemia is an independent risk factor for the development of surgical site infection following gastrointestinal surgery: a multi-institutional study","volume":"252","author":"Hennessey","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2022.01.018_bib16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/jso.21161","article-title":"Elevated preoperative serum carcinoembrionic antigen level may be an effective indicator for needing adjuvant chemotherapy after potentially curative resection of stage II colon cancer.[J]","volume":"99","author":"Ogata","year":"2009","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2022.01.018_bib17","first-page":"5574","article-title":"Immunomarker support vector machine classifier for prediction of gastric cancer survival and adjuvant chemotherapeutic benefit","volume":"24","author":"Jiang","year":"2018","journal-title":"J\u00a0Clin Case Rep"},{"key":"10.1016\/j.ejso.2022.01.018_bib18","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/bjs.11461","article-title":"Machine learning to predict early recurrence after oesophageal cancer surgery.[J]","volume":"107","author":"Rahman","year":"2020","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2022.01.018_bib19","doi-asserted-by":"crossref","DOI":"10.1007\/s00259-020-04771-5","article-title":"Histologic subtype classification of non-small cell lung cancer using PET\/CT images.[J]","author":"Han","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ejso.2022.01.018_bib20","doi-asserted-by":"crossref","first-page":"102811","DOI":"10.1016\/j.ebiom.2020.102811","article-title":"Machine learning-based genome-wide interrogation of somatic copy number aberrations in circulating tumor DNA for early detection of hepatocellular carcinoma","volume":"56","author":"Tao","year":"2020","journal-title":"[J] .EBioMedicine"},{"key":"10.1016\/j.ejso.2022.01.018_bib21","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1186\/s12885-019-6213-0","article-title":"Exploring the value of new preoperative inflammation prognostic score: white blood cell to hemoglobin for gastric adenocarcinoma patients","volume":"19","author":"Zheng","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejso.2022.01.018_bib22","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1007\/s00595-017-1469-y","article-title":"A\u00a0decrease in the prognostic nutritional index is associated with a worse long-term outcome in gastric cancer patients undergoing neoadjuvant chemotherapy","volume":"47","author":"Migita","year":"2017","journal-title":"Surg Today"},{"key":"10.1016\/j.ejso.2022.01.018_bib23","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ijsu.2018.06.037","article-title":"Can the neutrophil lymphocyte ratio and platelet-lymphocyte ratio be beneficial in predicting lymph node metastasis and promising prognostic markers of gastric cancer patients? Tumor maker retrospective study","volume":"56","author":"Zhang","year":"2018","journal-title":"Int J Surg"},{"key":"10.1016\/j.ejso.2022.01.018_bib24","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.2147\/OTT.S140118","article-title":"Monocyte to lymphocyte ratio predicts survival in patients with advanced gastric cancer undergoing neoadjuvant chemotherapy","volume":"10","author":"Chen","year":"2017","journal-title":"OncoTargets Ther"},{"key":"10.1016\/j.ejso.2022.01.018_bib25","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10120-018-0854-6","article-title":"Prognostic importance of the preoperative modified systemic inflammation score for patients with gastric cancer","volume":"22","author":"Lin","year":"2019","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.ejso.2022.01.018_bib26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s40880-017-0243-2","article-title":"Prognostic value of systemic immune-inflammation index in patients with gastric cancer","volume":"36","author":"Wang","year":"2017","journal-title":"Chin J Cancer"},{"issue":"1","key":"10.1016\/j.ejso.2022.01.018_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10120-016-0622-4","article-title":"Japanese gastric cancer treatment guidelines 2014 (ver. 4)","volume":"20","author":"Japanese Gastric Cancer","year":"2017","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.ejso.2022.01.018_bib28","series-title":"Jr regression modeling strategies: with applications to linear models, logistic and ordinal regression, and survival analysis. Springer series in statistics","first-page":"63","article-title":"Multivariable modeling strategies","author":"Harrell","year":"2015"},{"year":"2020","series-title":"The relationship between lymph node ratio and survival benefit with adjuvant chemotherapy in node-positive esophageal adenocarcinoma.[J]","author":"Raman","key":"10.1016\/j.ejso.2022.01.018_bib29"},{"issue":"3","key":"10.1016\/j.ejso.2022.01.018_bib30","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/SLA.0000000000002971","article-title":"Clinical importance of mean corpuscular volume as a prognostic marker after esophagectomy for esophageal cancer: a retrospective study","volume":"271","author":"Yoshida","year":"2020","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.ejso.2022.01.018_bib31","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/jso.20272","article-title":"Pretreatment anemia is associated with poorer survival in patients with stage I and II gastric cancer","volume":"91","author":"Shen","year":"2005","journal-title":"J\u00a0Surg Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2022.01.018_bib32","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.3748\/wjg.v11.i11.1582","article-title":"Nutritional status and quality of life of the gastric cancer patients in Changle County of China","volume":"11","author":"Tian","year":"2005","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.ejso.2022.01.018_bib33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000471931","article-title":"Perioperative serum carcinoembryonic antigen levels predict recurrence and survival of patients with pathological T2-4 gastric cancer treated with curative gastrectomy","volume":"35","author":"Uda","year":"2018","journal-title":"Dig Surg"},{"key":"10.1016\/j.ejso.2022.01.018_bib34","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1093\/jjco\/29.11.550","article-title":"Tumor markers CEA, CA19-9 and CA125 in monitoring of response to systemic chemotherapy in patients with advanced gastric cancer","volume":"29","author":"Yamao","year":"1999","journal-title":"Jpn J Clin Oncol"},{"issue":"9255","key":"10.1016\/j.ejso.2022.01.018_bib35","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: back to Virchow?","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet"},{"issue":"7203","key":"10.1016\/j.ejso.2022.01.018_bib36","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ejso.2022.01.018_bib37","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1245\/s10434-018-6684-2","article-title":"Parameters for predicting surgical outcomes for gastric cancer patients: simple is better than complex.[J]","volume":"25","author":"Ali","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.01.018_bib38","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/bjs.10425","article-title":"Systemic inflammatory markers and outcome in patients with locally advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction.[J]","volume":"104","author":"Jagadesham","year":"2017","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2022.01.018_bib39","article-title":"Anemia in Cancer: therapeutic implications and interventions","volume":"2","author":"Gillespie","year":"2003","journal-title":"Cancer Nurs"},{"issue":"7","key":"10.1016\/j.ejso.2022.01.018_bib40","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1007\/s00268-005-0756-8","article-title":"Preoperative enteral immunonutrition improves postoperative outcome in patients with gastrointestinal cancer","volume":"30","author":"Xu","year":"2006","journal-title":"World J Surg"},{"issue":"5","key":"10.1016\/j.ejso.2022.01.018_bib41","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.clnu.2008.07.009","article-title":"A\u00a0rational approach to nutritional assessment","volume":"27","author":"Soeters","year":"2008","journal-title":"Clin Nutr"},{"issue":"Suppl 2","key":"10.1016\/j.ejso.2022.01.018_bib42","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.ejon.2005.09.007","article-title":"The causes and consequences of cancer associated malnutrition","volume":"9","author":"Van Cutsem","year":"2005","journal-title":"Eur J Oncol Nurs"},{"issue":"19","key":"10.1016\/j.ejso.2022.01.018_bib43","doi-asserted-by":"crossref","first-page":"5961","DOI":"10.3748\/wjg.v21.i19.5961","article-title":"Novel immunological and nutritional based prognostic index for gastric cancer","volume":"21","author":"Sun","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejso.2022.01.018_bib44","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1186\/1477-7819-12-397","article-title":"Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy","volume":"12","author":"Sun","year":"2014","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.ejso.2022.01.018_bib45","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1245\/s10434-013-3066-7","article-title":"Prognostic value of early postoperative tumor marker response in gastric cancer","volume":"20","author":"Nam","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.01.018_bib46","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4143\/crt.2008.40.1.16","article-title":"Prognostic significance of serum and tissue carcinoembryonic antigen in patients with gastric adenocarcinomas","volume":"40","author":"Park","year":"2008","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.ejso.2022.01.018_bib47","first-page":"863","article-title":"Prognostic value of preoperative serum levels of five tumor markers (carcinoembryonic antigen, CA19-9, alpha-fetoprotein, CA72-4, and CA125) in gastric cancer","volume":"61","author":"Kim","year":"2014","journal-title":"Hepato-Gastroenterology"},{"issue":"4","key":"10.1016\/j.ejso.2022.01.018_bib48","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.surg.2015.11.002","article-title":"Recurrence of gastric cancer in patients who are disease-free for more than 5 years after primary resection","volume":"159","author":"Lee","year":"2016","journal-title":"Surgery"},{"issue":"3","key":"10.1016\/j.ejso.2022.01.018_bib49","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/SLA.0000000000003238","article-title":"Stratification of postsurgical computed tomography surveillance based on the extragastric recurrence of early gastric cancer.[J]","volume":"272","author":"Seo","year":"2020","journal-title":"Ann. Surg."},{"issue":"2","key":"10.1016\/j.ejso.2022.01.018_bib50","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/bjc.2013.712","article-title":"Death-associated protein-3, DAP-3, correlates with preoperative chemotherapy effectiveness and prognosis of gastric cancer patients following perioperative chemotherapy and radical gastrectomy","volume":"110","author":"Jia","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejso.2022.01.018_bib51","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.21143","article-title":"Development and validation of a computed tomography-based radiomics signature to predict response to neoadjuvant chemotherapy for locally advanced gastric cancer.[J]","volume":"4","author":"Wang","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ejso.2022.01.018_bib52","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/j.ejca.2011.02.024","article-title":"DNA methyltransferase 1 as a predictive biomarker and potential therapeutic target for chemotherapy in gastric cancer.[J]","volume":"47","author":"Kathrin","year":"2011","journal-title":"Eur J Cancer"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798322000440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798322000440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:44:10Z","timestamp":1760060650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798322000440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":51,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0748798322000440"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2022.01.018","relation":{},"ISSN":["0748-7983"],"issn-type":[{"type":"print","value":"0748-7983"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel hematological classifier predicting chemotherapy benefit and recurrence hazard for locally advanced gastric cancer A multicenter IPTW analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2022.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}